Edition:
United States

Eisai Co Ltd (ESALF.PK)

ESALF.PK on OTC Markets Group - US Other OTC and Grey Market

53.00USD
--
Change (% chg)

$0.00 (+0.00%)
Prev Close
$53.00
Open
--
Day's High
--
Day's Low
--
Volume
300
Avg. Vol
348
52-wk High
$63.50
52-wk Low
$51.25

Summary

Name Age Since Current Position

Haruo Naito

69 2014 Chief Executive Officer, Representative Executive Officer, Director

Ryohei Yanagi

54 2015 Managing Executive Officer, Chief Financial Officer, Chief IR Officer

Hideki Hayashi

59 2016 Representative Executive Officer, Chief Information Officer

Junichi Asatani

56 2014 Chief Compliance Officer, Executive Officer

Kenta Takahashi

57 2016 General Counsel, Managing Executive Officer, President of Subsidiary

Takafumi Asano

60 2016 Senior Managing Executive Officer, President of Eisai Demand Chain Systems

Yasushi Okada

58 2013 Senior Managing Executive Officer, Chief Talent Officer, Chief Director of Human Resources Development

Ivan Cheung

40 2016 Managing Executive Officer, President of Neurology Business Group, President of America Region, Chairman & Chief Executive Officer of Subsidiary

Edward Geary

54 2013 Managing Executive Officer, Chief Medical Officer, Chief Director of Corporate Medical Affairs, Chairman of Global Safety Board

Gary Hendler

50 2016 Managing Executive Officer, President of EMEA Region, Chief Commercial Officer of Oncology Business Group, President & Chief Executive Officer of Subsidiary

Terushige Iike

53 2016 Managing Executive Officer, President of Oncology Business Group

Yuji Matsue

57 2016 Managing Executive Officer, Deputy Chief Talent Officer

Yanhui Feng

44 2016 Executive Officer, General Manager of Subsidiaries

Yasunobu Kai

55 2016 Executive Officer, Director of Strategy, Chief Strategy Officer of Oncology Business Group, Lembima Global Lead

Hiroyuki Kato

59 2016 Executive Officer, Manager of Medicine Development Center

Teiji Kimura

54 2016 Executive Officer, Director of Neurology Tsukuba Research Department, Chief Discovery Officer of Neurology Business Group

Lynn Kramer

66 2016 Executive Officer, Chief Clinical Officer of Neurology Business Group, Chief Medical Officer

Masayuki Miyajima

54 2016 Executive Officer, President of Subsidiary

Takashi Ohwa

53 2016 Executive Officer, Chief Medicine Creation Officer of Oncology Business Group, Chief Discovery Officer

Shaji Procida

45 2014 Executive Officer, President of Subsidiary

Sayoko Sasaki

48 2015 Executive Officer

Alexander Scott

51 2016 Executive Officer, Director of Strategy, Chief Strategy Officer of Neurology Business Group

Rami Suzuki

43 2016 Executive Officer, Director of Corporate BD

Hidenori Yabune

46 2016 Executive Officer, Chief Director of Eisai Japan Access and Outcome

Satoru Yasuda

55 2016 Executive Officer, Chief Director of Eisai Japan Area Community Collaboration Metropolitan Area

Tatsuyuki Yasuno

48 2016 Executive Officer, Director of Corporate Planning & Strategy

Hideshi Honda

62 2014 Representative Executive Officer, President of Asia Region

Yutaka Tsuchiya

64 2014 Representative Executive Officer

Nobuo Deguchi

69 2012 Director

Hirokazu Kanai

57 2016 Director

Noboru Naoe

61 2014 Director

Graham Fry

67 2012 Independent Director

Tamaki Kakizaki

56 2016 Independent Director

Yasuhiko Kato

69 2016 Independent Director

Ikuo Nishikawa

65 2014 Independent Director

Eiichiro Suhara

68 2015 Independent Director

Daiken Tsunoda

50 2016 Independent Director

Toru Yamashita

69 2014 Independent Director

Shinya Watanabe

2016 Director of Accounting in Main Finance & Accounting Unit

Biographies

Name Description

Haruo Naito

Mr. Haruo Naito has been serving as Chief Executive Officer, Representative Executive Officer and Director of Eisai Co., Ltd. since June 2014. He is also working for The Naito Foundation. He joined the Company in October 1975. His previous titles include Director of Research and Development Promotion, Chief Director of Research and Development, Managing Director, Senior Managing Director, Vice President and Representative Director in the Company. He used to serve as President and Representative Director of another pharmaceutical company.

Ryohei Yanagi

Mr. Ryohei Yanagi has been serving as Managing Executive Officer, Chief Financial Officer and Chief IR Officer of Eisai Co., Ltd. since June 2015. He joined the Company in September 2009. He previously served as Executive Officer in the Company.

Hideki Hayashi

Mr. Hideki Hayashi has been serving as Representative Executive Officer and Chief Information Officer in Eisai Co., Ltd. since April 2016. He joined the Company in April 1981. His previous titles include Senior Managing Executive Officer, Executive Officer, Managing Executive Officer and Director of Business Development in the Company.

Junichi Asatani

Mr. Junichi Asatani has been serving as Chief Compliance Officer and Executive Officer of Eisai Co., Ltd. since June 2014. He joined the Company in April 1985. He previously served as Director of Compliance & Risk Management Promotion in the Company.

Kenta Takahashi

Mr. Kenta Takahashi has been serving as General Counsel and Managing Executive Officer in Eisai Co., Ltd. as well as President and Representative Director of a subsidiary since April 2016. He joined the Company in April 1983. He previously served as Executive Officer in the Company.

Takafumi Asano

Mr. Takafumi Asano has been serving as Senior Managing Executive Officer and President of Eisai Demand Chain Systems in Eisai Co., Ltd. since 2016. He joined the Company in April 1980. His previous titles include Deputy Chief Director of Demand Chain, Director of Production Planning, Managing Executive Officer, Director of Drug Production in Misato Plant and Kawashima Plant Manager in the Company.

Yasushi Okada

Mr. Yasushi Okada has been serving as Senior Managing Executive Officer, Chief Talent Officer and Chief Director of Human Resources Development in Eisai Co., Ltd. since June 2013. He joined the Company in April 1981. His previous titles include Director of Business Planning, Director of Business Promotion in Pharmaceutical Business Unit, Director of Business Strategy in Pharmaceutical Business Unit, Managing Executive Officer and Director of Planning in Main Japan Business Main Unit in the Company.

Ivan Cheung

Mr. Ivan Cheung has been serving as Managing Executive Officer, President of Neurology Business Group and President of America Region in Eisai Co., Ltd. as well as Chairman and Chief Executive Officer of a subsidiary since April 2016. He joined the Company in October 2005. He used to serve as Director of Promotion in Main Product Creation Unit in CEO's Office, Deputy Chief Director of Human Resources Development and Director of Talent Management and Director of Business Strategy in the Company.

Edward Geary

Mr. Edward Stewart Geary has been serving as Managing Executive Officer, Chief Medical Officer, Chief Director of Corporate Medical Affairs and Chairman of Global Safety Board in Eisai Co., Ltd. since June 2013. He joined the Company in April 1997. His previous titles include Director of Pharmaceutical Business Policy, Executive Officer and Deputy Chief Director of Reliability Assurance in the Company. He worked for Stanford University before joining the Company.

Gary Hendler

Mr. Gary Hendler has been serving as Managing Executive Officer, President of EMEA Region and Chief Commercial Officer of Oncology Business Group in Eisai Co., Ltd. as well as President and Chief Executive Officer of a subsidiary, Eisai Europe Ltd., since April 2016. He used to work for another subsidiary.

Terushige Iike

Mr. Terushige Iike has been serving as Managing Executive Officer and President of Oncology Business Group in Eisai Co., Ltd., since April 2016. He joined the Company in April 1986.

Yuji Matsue

Mr. Yuji Matsue has been serving as Managing Executive Officer and Deputy Chief Talent Officer in Eisai Co., Ltd., since April 2016. He joined the Company in April 1981. His previous titles include Director of Investor Relations, President of Indo-Pacific Region and Director of Talent Management in Main Human Resources Development Unit in the Company.

Yanhui Feng

Yanhui Feng has been serving as Executive Officer of Eisai Co., Ltd. as well as General Manager of two subsidiaries since April 2016. Yanhui joined the subsidiary of the Company in December 2012.

Yasunobu Kai

Mr. Yasunobu Kai has been serving as Executive Officer, Director of Strategy, Chief Strategy Officer of Oncology Business Group and Lembima Global Lead in Eisai Co., Ltd. since April 2016. He joined the Company in April 1986. He used to be President of Frontier Drug Development Unit and President of Eisai Value Maximization Systems in the Company.

Hiroyuki Kato

Mr. Hiroyuki Kato has been serving as Executive Officer and Manager of Medicine Development Center in Eisai Co., Ltd. since April 2016. He joined the Company in April 1982.

Teiji Kimura

Mr. Teiji Kimura has been serving as Executive Officer, Director of Neurology Tsukuba Research Department and Chief Discovery Officer of Neurology Business Group in Eisai Co., Ltd. since April 2016. He joined the Company in April 1987.

Lynn Kramer

Dr. Lynn Kramer has been serving as Executive Officer, Chief Clinical Officer of Neurology Business Group and Chief Medical Officer in Eisai Co., Ltd. since April 2016. He used to work for Eisai Inc.

Masayuki Miyajima

Mr. Masayuki Miyajima has been serving as Executive Officer of Eisai Co., Ltd. as well as President of a subsidiary since April 2016. He joined the Company in April 1985.

Takashi Ohwa

Mr. Takashi Ohwa has been serving as Executive Officer, Chief Medicine Creation Officer of Oncology Business Group and Chief Discovery Officer in Eisai Co., Ltd. since April 2016. He joined the Company in April 1991. He used to be Director of 2nd Drug Development Research Institute and President of Oncology Drug Development Unit in the Company.

Shaji Procida

Ms. Shaji Procida has been serving as Executive Officer of Eisai Co., Ltd., as well as President and Chief Operating Officer of a subsidiary, Eisai Inc., since June 2014. She used to work for another company.

Sayoko Sasaki

Ms. Sayoko Sasaki has been serving as Executive Officer in Eisai Co., Ltd. since April 1, 2015. She joined the Company in April 1991.

Alexander Scott

Mr. Alexander Scott has been serving as Executive Officer, Director of Strategy and Chief Strategy Officer of Neurology Business Group in Eisai Co., Ltd. since April 2016. He used to work for a subsidiary of the Company.

Rami Suzuki

Mr. Rami Suzuki has been serving as Executive Officer and Director of Corporate BD of Eisai Co., Ltd. since April 2016. He joined the Company in October 2006.

Hidenori Yabune

Mr. Hidenori Yabune has been serving as Executive Officer and Chief Director of Eisai Japan Access and Outcome in Eisai Japan in Eisai Co., Ltd. since April 2016. He joined the Company in April 1994.

Satoru Yasuda

Mr. Satoru Yasuda has been serving as Executive Officer and Chief Director of Eisai Japan Area Community Collaboration Metropolitan Area in Eisai Co., Ltd. since April 2016. He joined the Company in April 1985.

Tatsuyuki Yasuno

Mr. Tatsuyuki Yasuno has been serving as Executive Officer and Director of Corporate Planning & Strategy of Eisai Co., Ltd. since April 2016. He joined the Company in April 1991.

Hideshi Honda

Mr. Hideshi Honda has been serving as Representative Executive Officer and President of Asia Region of Eisai Co., Ltd. since June 2014. He joined the Company in April 1977. His previous titles include Managing Executive Officer, Director of International and Business development, Executive Officer, Deputy Chief Director of Global Pharmaceutical, Vice President, President of East Asia Region and Deputy Director of Cosmetic Medicine in the Company.

Yutaka Tsuchiya

Mr. Yutaka Tsuchiya has been serving as Representative Executive Officer of Eisai Co., Ltd. since June 2014. He joined the Company in April 1975. His previous titles include Executive Officer, Director of Planning in Clinical Test Research Center, Managing Executive Officer, Senior Managing Executive Officer and Chief Director of Reliability Assurance in the Company. He also used to be Chairman of the Board and Chief Executive Officer in an United Kingdom-based subsidiary.

Nobuo Deguchi

Mr. Nobuo Deguchi has been serving as Director of Eisai Co., Ltd. since June 2012. He joined the Company in March 1970. His previous titles include Vice President, Chief Compliance Officer, Representative Executive Officer, Senior Managing Executive Officer, Director of Internal Control Promotion, Executive Officer and Managing Executive Officer in the Company. He used to serve as President and Representative Director in a subsidiary.

Hirokazu Kanai

Mr. Hirokazu Kanai has been serving as Director of Eisai Co., Ltd. since June 2016. He is also a member of Audit Committee of the Company. He joined the Company in April 1983.

Noboru Naoe

Mr. Noboru Naoe has been serving as Director of Eisai Co., Ltd. since June 2014. He is also a member of Audit Committee of the Company. He joined the Company in April 1978. His previous titles include Executive Officer, Deputy Director of Pharmaceutical Business, Director of Medicine Business, Senior Director of Medicine in Main Japan Business Unit, Managing Executive Officer and President of Eisai Japan in the Company.

Graham Fry

Mr. Graham Fry has been serving as Independent Director in Eisai Co., Ltd. since June 2012. He is also a member of Nominating Committee, and Chairman of Compensation Committee of the Company. He used to work for British Foreign & Commonwealth Office.

Tamaki Kakizaki

Mr. Tamaki Kakizaki has been serving as Independent Director in Eisai Co., Ltd. since June 2016. He is also a member of Audit Committee of the Company. He is also a Professor in Meiji University.

Yasuhiko Kato

Mr. Yasuhiko Kato has been serving as Independent Director in Eisai Co., Ltd. since June 2016. He is also a member of Compensation and Nomination Committee of the Company. He is also serving as Chairman of the Board and Representative Director of Mitsui Engineering & Shipbuilding Co.,ltd.

Ikuo Nishikawa

Mr. Ikuo Nishikawa has been serving as Independent Director in Eisai Co., Ltd. since June 2014. He is also Chairman of Audit Committee of the Company. He is also working for Megmilk Snow Brand Company, Limited. He is also a professor of Keio University, He used to work for Ernst & Young ShinNihon LLC.

Eiichiro Suhara

Mr. Eiichiro Suhara has been serving as Independent Director in Eisai Co., Ltd. since June 2015. He is also a member of Nomination Committee and Compensation Committee of the Company. He is also serving as Independent Director in YOKOHAMA SHINKO Co., Ltd. as well as President and Representative Director in MITSUBISHI PENCIL CO., LTD.

Daiken Tsunoda

Mr. Daiken Tsunoda has been serving as Independent Director in Eisai Co., Ltd. since June 2016. He is also a member of Audit Committee of the Company. He is also serving as Independent Director in MS&AD Insurance Group Holdings, Inc. as well as Culture Convenience Club Co.,Ltd., working for three other companies as well as working for a legal firm.

Toru Yamashita

Mr. Toru Yamashita has been serving as Independent Director in Eisai Co., Ltd. since June 2014. He is a also Chairman of Nominating Committee, and a member of Compensation Committee of the Company. He is also serving as Independent Director in Mitsui Fudosan Co., Ltd., as well as Sumitomo Life Insurance Company and working for NTT DATA CORPORATION. He used to work for Nippon Telegraph and Telephone Public Corporation.

Shinya Watanabe